Skip to main navigation Skip to search Skip to main content

A 2021 update on syphilis: Taking stock from pathogenesis to vaccines

  • Giorgio Tiecco
  • , Melania Degli Antoni
  • , Samuele Storti
  • , Valentina Marchese
  • , Emanuele Focà
  • , Carlo Torti
  • , Francesco Castelli
  • , Eugenia Quiros-Roldan*
  • *Corresponding author for this work
  • University of Brescia
  • Magna Græcia University

Research output: Contribution to journalReview articleAcademicpeer-review

22 Downloads (Pure)

Abstract

In 2021 the scientific community’s efforts have been focused on solving the back-breaking challenge of the COVID-19 pandemic, but sexually transmitted infections (STI) are still one of the most common global health problems. Syphilis is a systemic disease caused by the spirochaete Treponema pallidum (TP) and is one of the oldest known diseases. Its incidence has increased in the last few years and syphilis still remains a contemporary plague that continues to afflict millions of people worldwide. Despite research improvements, syphilis pathogenesis is not completely clear; clinical presentation is very heterogeneous and the diagnosis can sometimes be difficult. Furthermore, few therapeutic options are available, and a vaccine has not been found yet. In this review, we describe the most recent evidence concerning the clinical manifestation, diagnosis, treatment and vaccine prospectives for this disease.
Original languageEnglish
Article number1364
JournalPathogens
Volume10
Issue number11
DOIs
Publication statusPublished - 1 Nov 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A 2021 update on syphilis: Taking stock from pathogenesis to vaccines'. Together they form a unique fingerprint.

Cite this